fibromyalgia
play

Fibromyalgia and Morbidity Pathogenesis, Diagnosis and Therapeutic - PDF document

A Major Cause of Disability Fibromyalgia and Morbidity Pathogenesis, Diagnosis and Therapeutic Options 25.3% of patients 31% of patients received disability employed prior to payments; (Wolfe, onset of their fm 1996) reported loss


  1. A Major Cause of Disability Fibromyalgia and Morbidity Pathogenesis, Diagnosis and Therapeutic Options • 25.3% of patients • 31% of patients received disability employed prior to payments; (Wolfe, onset of their fm 1996) reported loss of Kevin V. Hackshaw, M.D. employment due to • 27.8% of patients Associate Professor of Medicine their disease were (Thorson, 1998) Division of Immunology/ Rheumatology seeking/receiving Fellowship Director - Rheumatology disability; (Robinson, 2007; J The Ohio State University Pain) Columbus, Ohio Associated Conditions Fibromyalgia • Neuralgia • Neurasthenia • A chronic musculoskeletal pain • Muscular Rheumatism amplification syndrome • Psychogenic Rheumatism • Fatigue • Tension Rheumatism • Fibrositis/ Myofibrositis • Wide spread muscular aching • Chronic Fatigue Syndrome • Sleep disturbance • Shell Shock • Post Traumatic Stress Syndrome • Temperature intolerance • Gulf War Syndrome • Chemical Hypersensitivity Syndrome • Sick Building Syndrome 1

  2. Demographics “Pain” • Female > Male (5:1) * • Age Onset: 9 – 60 • An unpleasant sensory and emotional • Most commonly between 40 and 60 experience associated with actual or potential tissue damage • All Races • Between 3 – 7% of the U.S. population is affected • Inciting events: Trauma (**), Infection, MVA with whiplash, Head or Neck Injury Pain Mechanisms • Nociceptive transmission: arising from inflammation or degeneration of joints and Pain Mechanisms soft tissue • Examples: Rheumatoid Arthritis and Osteoarthritis 2

  3. Peripheral and Spinal Pain Mechanisms Pain Mechanisms • Neuropathic transmission: arising from a primary lesion in the peripheral or central nervous system • Central endings - spinal cord gray matter • Modulating factors {5HT – High presynaptic • Hyperresponsiveness to subthreshold stimuli levels inhibit NT release, low levels enhance NT • Examples: Trigeminal Neuralgia, Diabetic release} Peripheral Neuropathy, Post herpetic neuralgia, • Neurotransmitters Fibromyalgia (?) � Substance P (NK1 receptors; long acting) � Nociceptive � Glutamate (NMDA receptors; short acting) � Inflammatory � Excitatory Amino Acids � Vasoactive intestinal peptide (visceral organs) � Neuropathic � CGRP � Maladaptive Peripheral and Spinal Pain Mechanisms • Nociceptive afferents � A delta myelinated (fast transmission ) � C unmyelinated (slow transmission) 3

  4. Mechanisms of Descending Controls Neuropathic Pain • Modulation of nociceptive processing and pain • Spontaneous discharges either peripherally or centrally � Perceptual correlates • Localized demyelination, DRG abnormalities or � Placebo effect aberrant Sodium or Calcium channels may � Hypnosis and suggestion contribute � Combat, athletics • Aberrant expression of neurotransmitters in periphery or centrally leads to “Sensitization” � Ritual analgesia • Results is more ectopic firing � Pharmacological analgesia Pain Processing Areas in the Brain Somatosensory Prefrontal Cortex Cortex Insular Cortex Anterior Cingulate Cortex Thalamus Amygdala 4

  5. Fibromyalgia Spectrum • Seek Medical Care • Don’t seek medical care • Multiple tender Clinical Presentation points • Multiple tender points • Depression * • Anxiety * • High frequency of recent stressful experiences Rheumatic Symptoms • Allodynia • Hyperalgesia � A non-noxious � An exagerrated • General aches/ pains stimulus elicits response to a • Articular pains without joint swelling pain painful stimulus • Morning stiffness about 1 hour • Subjective morning swelling 5

  6. Diagnostic Criteria Non-Rheumatic Symptoms • Anxiety • * Widespread subjective aching for more than 3 months • Sleep disturbances • *Pain in >11 of 18 tender points * • Headaches • Subjective stiffness of more than 3 months • Irritable bowel syndrome • Pain in all 4 quadrants of body • Irritable bladder • PMS • “Normal Labs” to include ESR, TSH, ANA, Vitamin D Level, etc. • Numbness • Concurrent chronic fatigue, emotional distress, • Palpitations poor sleep, morning stiffness *specific • Mottled skin appearance diagnostic criteria • Temperature instability Fibromyalgia Tender Points Other Considerations… 6

  7. Pain Catastrophizing -1 Pain Catastrophizing -3 • Describing pain as “awful, horrible or • Individuals who catastrophize have difficulty unbearable” shifting their focus of attention away from painful or threatening stimuli • Early studies suggested these maladaptive responses mirrored responses in depressed • They attach more threat or harm to non-painful individuals stimuli (Crombez 1998, 2002) • Later studies have found catastrophizing to be • Catastrophizing is also associated with affective significantly associated with pain related pain ratings leading to higher evaluations of the disability independent of depression or negative experience of pain (Geisser 1994) affect (Keefe 1989, Geiser 1994, 2003) Waddell Signs Pain Catastrophizing -2 • Tenderness � Superficial - skin is tender to light pinch over a wide • Independent of influence of depression: area of lumbar skin nonanatomic - deep tenderness • Associated with brain areas associated with over a wide area, not localized to one structure anticipation of pain: medial frontal cortex, • Simulation Tests - give the impression that an cerebellum; examination is being done, when in fact it is • Attention to pain : Dorsal ACC, Dorsal prefrontal not cortex; � Axial loading - vertical loading over the • Emotional aspects of pain: Claustrum, closely standing patient’s skull by the examiner’s connected to amygdala and motor control hands rotation - turn standing patient to one side by rotating lower extremities (not spine) 7

  8. Waddell Signs • Distraction Tests - reevaluating a positive finding while the patient’s attention is not focused on the test � Indirect observation - can patient move the body part without pain when not being directly examined? Pathogenesis � Straight leg raise - if positive when examined supine, do "flip test" (sitting SLR) • Regional Disturbances - widespread divergence from accepted neuroanatomy � Weakness - "cogwheeling" or many muscle groups that cannot be explained neuroanatomically � Sensory - "stocking" distribution of sensory changes • Overreaction � Disproportionate verbalization, facial expression, muscle tension and tremor, collapsing, sweating Phasic alpha wave intrusion Comorbidity patterns correlate with clinical symptoms in fibromyalgia • 25% of RA with FM • 30% of SLE with FM • 50% of SS with FM • 20 -80% of DM with FM • MS with FM 8

  9. Family and Genetic Studies Genetic influences on pain sensitivity may in part mediate • Odds ratio for a family member of a the relation between patient with FM to also have FM is 8.5 somatization and the (Arnold, 2004) development of widespread pain • FM family members have increased pain sensitivity as measured by total myalgic score Women with abnormal pain sensitivity or chronic widespread pain show a functional polymorphism in the promoter region of the serotonin transporter gene 5-HTT. 9

  10. Correlation between levels of CSF BDNF and Glutamate in FM Patients Substance P in CSF • No significant relationship with depression (Russell , 1994) • No difference in CSF SP levels between individuals with major depression and normal controls (Deuschle, 2005) • CSF SP levels are unchanged by antidepressant treatment / response (Deuschle, 2005) NGF is elevated in CSF NGF and BDNF in of Primary Fibromyalgia CSF of FM Table - CSF Levels of NGF and BDNF (Mean +/- 2 SD) in Patient Groups and Controls • Primary FM: 41.8 +/- 12.7 pg/ml CM PATIENTS PFMS CONTROLS NGF (pg/mL) 46.7 4.6 47.2 5.3 13.7 2.7 • Secondary FM: 8.9 +/- 4.4 pg/ml BDNF (pg/mL) 39.4 6.7 40.4 4.6 11.3 3.4 Glutamate (mol/L) 2.18 0.4 2.36 0.3 1.37 0.3 • Other : 16.2 +/- 8.4 pg/ml * * Abbreviations: CM, chronic migraine; PFMS, primary fibromyalgia syndrome; NGF, nerve growth factor; BDNF, brain-derived neurotrophic factor. * = Statistically Significant Sarchielli et al., 2007 Giovengo et al., 1999 10

  11. Question? Changing Glutamate Levels in Insula “Does the pattern of brain activation in FM patients match that produced by equally low correlate with stimulus pressures in normal volunteers, or does Fibromyalgia Pain it match that produced by equally subjectively painful stimuli (produced by significantly greater stimulus pressures) in the normal volunteer H-MRS (proton magnetic group?” A match of equal subjective pain intensities is consistent with a pathologic resonance spectroscopy) increase in pain sensitivity in patients. (Gracely et al., 2008) FM patients report pain at Functional Imaging normally painless pressures Techniques • PET Scanning • Functional MRI • Studies by K. Casey, Peyron • Pain is associated with activation in the Secondary Somatosensory(SII), Insular Region, Anterior Cingulate Cortex (ACC), contra lateral thalamus and primary somatosensory cortex (SI) • Activation is characterized by an increase in Regional Cerebral Blood Flow Gracely et al, 2002 11

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend